Why TG Therapeutics, Inc. Shares Jumped

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of TG Therapeutics (NASDAQ: TGTX  ) , a clinical-stage biopharmaceutical company focused on developing therapies to treat cancer, jumped as much as 17% after announcing the sale of common stock to a single institutional investor after the closing bell last night.

So what: According to the press release from TG Therapeutics, it sold 2,702,809 shares of common stock at $6.71 (yesterday's closing price) to JPMorgan Asset Management's Global Healthcare Fund. The gross proceeds from the underwritten sale are approximately $18.1 million, which the company plans on using to fund the clinical development of TG-1101, a monoclonal antibody geared at treating B-cell proliferative disorders, and TGR-1202, a PI3K delta inhibitor that's being targeted at single-agent heme malignancies, as well as for general corporate purposes. The offering is expected to close on or before March 17.

Now what: Normally you don't see companies rally when they issue common stock, but given that shares are being underwritten at yesterday's closing price, it demonstrates that there's demand for the shares. In addition, the simple fact that one institutional fund is purchasing $18 million worth of TG Therapeutics has to be encouraging from a shareholder perspective. Including gross proceeds, this underwritten sale should move TG Therapeutics to around $68 million in cash on hand. I still would urge caution from shareholders, though, as TG Therapeutics' pipeline is fairly young and small. The aforementioned two experimental therapies represent the sum of its current studies, and only TG-1101 has completed its phase 1 study where it was deemed safe and early clinical activity was noted. I would suggest waiting for much more concrete data before diving into TG Therapeutics.

TG Therapeutics shares may be rocketing higher, but chances are it'll have a hard time keeping up with this top stock in 2014
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2873613, ~/Articles/ArticleHandler.aspx, 8/29/2015 7:45:50 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Sean Williams

A Fool since 2010, and a graduate from UC San Diego with a B.A. in Economics, Sean specializes in the healthcare sector and in investment planning topics. You'll usually find him writing about Obamacare, marijuana, developing drugs, diagnostics, and medical devices, Social Security, taxes, or any number of other macroeconomic issues.

Today's Market

updated 22 hours ago Sponsored by:
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 1.21 0.06%
NASD 4,828.33 15.62 0.32%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/28/2015 4:00 PM
TGTX $13.02 Up +0.40 +3.17%